Akarboza v profilaktike sakharnogo diabeta tipa 2
https://doi.org/10.14341/2072-0351-5933
Abstract
About the Authors
Marina Vladimirovna ShestakovaO Yu Breskina
References
1. American Diabetes Association. Diabetes Care 25: 742-749, 2002
2. Chiasson J-L, Gomis R, Hanefeld M, Josse RG, Karasik A, Laakso M, The STOP-NIDDM Trial Research Group. Diabetes Care 21: 1720-1725, 1998
3. Chiasson J-L, Gomis R, Hanefeld M, Josse RG, Karasik A, Laakso M, The STOP-NIDDM Trial Research Group. Lancet 2002, 359: 2072-77
4. Chiasson J-L, Gomis R, Hanefeld M, Josse RG, Karasik A, Laakso M, The STOP-NIDDM Trial Research Group. JAMA, 2003 ( в печати)
5. Diabetes Prevention Program Research Group. N Engl J Med, Vol. 346, No.6 - February 7, 2002; 393-403
6. Fontbonne A, Eschwege E, Cambien F, Richard J-L, Ducimetiere K, Thibult N etal. Diabetologia 1989; 32: 300-304
7. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Lancet 1980; 1373-1376
8. Pyorala K. Diabetes Care 1 979; 2:131-141
9. Tuomilehto J, Lindstrem J, Eriksson JG, Valle TT, Hamalainen H, llanne- Parikka P, Keinanen - Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M, for Finnish Diabetes Prevention Study Group. N Engl J Med, Vol. 344, No.18; May 3, 2001; 1343-1350
Review
For citations:
Shestakova M.V., Breskina O.Yu. Akarboza v profilaktike sakharnogo diabeta tipa 2. Diabetes mellitus. 2003;6(2):38-41. (In Russ.) https://doi.org/10.14341/2072-0351-5933

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).